Skip to search formSkip to main contentSkip to account menu

YM-09330

Known as: YM 09330, YM09330 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

CefotetanCefotetan Disodium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1983
1983
Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function
The elimination kinetics of cefotetan (YM09330), a new parenteral semisynthetic cephamycin derivative, were studied in eight… 
1982
1982
In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins
The comparative in vitro activity of N-formimidoyl thienamycin, cefmetazole, cefoxitin, cefotetan (YM-09330), and moxalactam… 
1982
1982
口腔外科領域の各種感染症に対するCefotetan (YM09330) の臨床成績
1982
1982
Cefotetan (YM09330) の実験動物における吸収, 分布, 代謝, 排泄
1982
1982
外科領域におけるCefotetan (YM09330) の臨床使用成績
1982
1982
Cefotetan (YM09330) のラットにおける腎毒性試験
1981
1981
Pharmacokinetics of new broad-spectrum cephamycin, YM09330, parenterally administered to various experimental animals
The pharmacokinetics of YM09330, a new semisynthetic cephamycin, were determined after intravenous and intramuscular… 
1981
1981
Purification and properties of cephalosporinase from Pseudomonas aeruginosa.
Cephalosporin beat-lactamase (cephalosporinase, CSase) was purified from a strain of Pseudomonas aeruginosa resistant to beta… 
1981
1981
Properties of cephalosporinase from Proteus morganii.
The cephalosporin beta-lactamase (cephalosporinase) was purified from a strain of Proteus morganii which showed resistance to… 
1981
1981
Comparative inhibition of beta-lactamases by cephamycin antibiotics.
Cefoxitin (CFX), cefmetazole (CMZ) and YM093301), and 6059-S2) have a 7a-methoxyl group (a unique structural feature of the…